Spirometry in primary care

被引：48

作者：

Coates, Allan L. ^{[1
]}

Graham, Brian L. ^{[2
]}

McFadden, Robin G. ^{[3
]}

McParland, Colm ^{[4
]}

Moosa, Dilshad ^{[5
]}

Provencher, Steeve ^{[6
]}

Road, Jeremy ^{[7
]}

机构：

[1] Hosp Sick Children, Div Resp Med, Toronto, ON M5G 1X8, Canada

[2] Univ Saskatchewan, Div Respirol Crit Care & Sleep Med, Saskatoon, SK, Canada

[3] Univ Western Ontario, Dept Med, Div Respirol, London, ON, Canada

[4] Dalhousie Univ, Div Respirol, Halifax, NS, Canada

[5] Ontario Lung Assoc, Provider Educ Program, Toronto, ON, Canada

[6] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Serv Pneumol, Quebec City, PQ, Canada

[7] Univ British Columbia, Div Resp, Vancouver, BC V5Z 1M9, Canada

来源：

CANADIAN RESPIRATORY JOURNAL | 2013年 / 20卷 / 01期

关键词：

Primary care; Pulmonary function; Quality control; Reference values; Spirometry; LUNG-FUNCTION; REFERENCE VALUES; EXPIRATORY FLOW; EQUATIONS; CHILDREN; QUALITY; ADULTS; HEALTH;

D O I：

10.1155/2013/615281

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

AL Coates, BL Graham, RG McFadden, et al. spirometry in primary care. can Respir J 2013; 20(1):13-22. Canadian Thoracic Society (CTS) clinical guidelines for asthma and chronic obstructive pulmonary disease (COPD) specify that spirometry should be used to diagnose these diseases. Given the burden of asthma and COPD, most people with these diseases will be diagnosed in the primary care setting. The present CTS position statement was developed to provide guidance on key factors affecting the quality of spirometry testing in the primary care setting. The present statement may also be used to inform and guide the accreditation process for spirometry in each province. Although many of the principles discussed are equally applicable to pulmonary function laboratories and interpretation of tests by respirologists, they are held to a higher standard and are outside the scope of the present statement.

引用

页码：13 / 21

页数：9

共 25 条

[1]

Borg BM, 2010, RESP CARE, V55, P689

[2] Effect of different inspiratory maneuvers on FEV(1) in patients with cystic fibrosis [J].

Braggion, C ;

Pradal, U ;

Mastella, G ;

Coates, AL ;

MilicEmili, J .

CHEST, 1996, 110 (03) :642-647

[3]

Centres for Disease Control and Prevention, NAT HLTH NUTR EX SUR

[4] VOLUME ADJUSTMENT OF MAXIMAL MID-EXPIRATORY FLOW - IMPORTANCE OF CHANGES IN TOTAL LUNG CAPACITY [J].

COCKCROFT, DW ;

BERSCHEID, BA .

CHEST, 1980, 78 (04) :595-600

[5] An update on contraindications for lung function testing [J].

Cooper, Brendan G. .

THORAX, 2011, 66 (08) :714-723

[6] SPIROMETRY IN THE LUNG HEALTH STUDY .1. METHODS AND QUALITY-CONTROL [J].

ENRIGHT, PL ;

JOHNSON, LR ;

CONNETT, JE ;

VOELKER, H ;

BUIST, AS .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (06) :1215-1223

[7]

GARDNER RM, 1986, AM REV RESPIR DIS, V134, P623

[8]

Gutierrez Carlos, 2004, Can Respir J, V11, P414

[9] Spirometric reference values from a sample of the general US population [J].

Hankinson, JL ;

Odencrantz, JR ;

Fedan, KB .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (01) :179-187

[10] SPIROMETRY IN THE ASTHMATIC CHILD - IS FEF25-75 A MORE SENSITIVE TEST THAN FEV(1)/FVC [J].

LEBECQUE, P ;

KIAKULANDA, P ;

COATES, AL .

PEDIATRIC PULMONOLOGY, 1993, 16 (01) :19-22

← 1 2 3 →